India expects minimal price changes for its pharma exports under new US tariffs, as punitive measures haven’t hit the sector ...

Billionaire entrepreneur and Cost Plus Drugs co-founder Mark Cuban won't have to raise medicine prices, as Trump’s new ...

The direct impact of higher US tariffs on India looks fluid as of now and a mutually beneficial trade deal by the end of this ...

Commerce Minister Piyush Goyal recently sparked a debate by challenging India's startup ecosystem to move beyond delivery ...

At the core of Kotak Private’s vision for its next phase of growth is a deep commitment to offering highly personalised, tech ...

AstraZeneca Pharma India announced that it has received approval from the Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, Government of India, to import ...

Indian pharmaceutical stocks took a hit as Trump's threat of imposing tariffs on pharma imports spooked investors. Despite ...

Shares of pharmaceutical companies on Friday tumbled more than 11% amid reports that the Trump administration will soon ...

The tariff shock will likely reflect in US inflation and growth outlook in the coming weeks. Investors are expected to ...

The United States is a key market for India’s pharmaceutical exports, with India supplying around 40 per cent of all generic ...

A unique argument - if the medicine for treatment of spinal muscular atrophy (SMA) is cheaper in Pakistan and China, why ...

Shares of pharmaceutical companies on Friday tumbled more than 11 per cent amid reports that the Trump administration will soon announce tariffs on pharma imports. According to reports, US President ...